Clinical Trials · NCT03598621
A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 68
- Start date
- Jul 2018
- Locations
- 2 sites, Germany
- Primary endpoint
- AUC0-last,sema,SD, the area under the plasma semaglutide concentration curve from time 0 until last quantifiable measurement after a single dose subcutaneous semaglutide administration